264 related articles for article (PubMed ID: 17785358)
1. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
Boden G; Vaidyula VR; Homko C; Cheung P; Rao AK
J Clin Endocrinol Metab; 2007 Nov; 92(11):4352-8. PubMed ID: 17785358
[TBL] [Abstract][Full Text] [Related]
2. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men.
Rao AK; Chouhan V; Chen X; Sun L; Boden G
Diabetes; 1999 May; 48(5):1156-61. PubMed ID: 10331423
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
[TBL] [Abstract][Full Text] [Related]
4. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand.
Vaidyula VR; Rao AK; Mozzoli M; Homko C; Cheung P; Boden G
Diabetes; 2006 Jan; 55(1):202-8. PubMed ID: 16380494
[TBL] [Abstract][Full Text] [Related]
5. Effects of hyperglycemia and hyperinsulinemia on the tissue factor pathway of blood coagulation.
Boden G; Rao AK
Curr Diab Rep; 2007 Jun; 7(3):223-7. PubMed ID: 17547839
[TBL] [Abstract][Full Text] [Related]
6. Whole-blood tissue factor procoagulant activity is elevated in type 1 diabetes: effects of hyperglycemia and hyperinsulinemia.
Singh A; Boden G; Homko C; Gunawardana J; Rao AK
Diabetes Care; 2012 Jun; 35(6):1322-7. PubMed ID: 22410811
[TBL] [Abstract][Full Text] [Related]
7. Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus.
Singh A; Boden G; Rao AK
Thromb Haemost; 2015 Apr; 113(4):750-8. PubMed ID: 25653143
[TBL] [Abstract][Full Text] [Related]
8. Platelet and monocyte activation by hyperglycemia and hyperinsulinemia in healthy subjects.
Vaidyula VR; Boden G; Rao AK
Platelets; 2006 Dec; 17(8):577-85. PubMed ID: 17127486
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia stimulates coagulation, whereas hyperinsulinemia impairs fibrinolysis in healthy humans.
Stegenga ME; van der Crabben SN; Levi M; de Vos AF; Tanck MW; Sauerwein HP; van der Poll T
Diabetes; 2006 Jun; 55(6):1807-12. PubMed ID: 16731846
[TBL] [Abstract][Full Text] [Related]
10. Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia.
Gentile NT; Vaidyula VR; Kanamalla U; DeAngelis M; Gaughan J; Rao AK
Thromb Haemost; 2007 Nov; 98(5):1007-13. PubMed ID: 18000605
[TBL] [Abstract][Full Text] [Related]
11. Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor-dependent pathway in healthy donors.
Topcuoglu P; Arat M; Dalva K; Ozcan M
Bone Marrow Transplant; 2004 Jan; 33(2):171-6. PubMed ID: 14647251
[TBL] [Abstract][Full Text] [Related]
12. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
13. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution.
De Smedt E; Wagenvoord R; Coen Hemker H
Thromb Haemost; 2009 Jan; 101(1):165-70. PubMed ID: 19132204
[TBL] [Abstract][Full Text] [Related]
14. Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation.
Rietveld IM; Schreuder M; Reitsma PH; Bos MHA
Thromb Res; 2018 Dec; 172():104-109. PubMed ID: 30408635
[TBL] [Abstract][Full Text] [Related]
15. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
Hattori T; Khan MM; Colman RW; Edmunds LH
J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
[TBL] [Abstract][Full Text] [Related]
16. Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease.
Rao AK; Vaidyula VR; Bagga S; Jalagadugula G; Gaughan J; Wilhite DB; Comerota AJ
Thromb Haemost; 2006 Dec; 96(6):738-43. PubMed ID: 17139367
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of the 78-kDa glucose-regulated protein/immunoglobulin-binding protein (GRP78/BiP) inhibits tissue factor procoagulant activity.
Watson LM; Chan AK; Berry LR; Li J; Sood SK; Dickhout JG; Xu L; Werstuck GH; Bajzar L; Klamut HJ; Austin RC
J Biol Chem; 2003 May; 278(19):17438-47. PubMed ID: 12621026
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity.
Lechner D; Kollars M; Gleiss A; Kyrle PA; Weltermann A
J Thromb Haemost; 2007 Dec; 5(12):2445-52. PubMed ID: 17922809
[TBL] [Abstract][Full Text] [Related]
19. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
[TBL] [Abstract][Full Text] [Related]
20. Impaired endothelial antithrombotic activity following short-term interruption of continuous subcutaneous insulin infusion in type 1 diabetic patients.
Iorio A; Federici MO; Mourvaki E; Ferolla P; Piroddi M; Stabile A; Timi A; Celleno R; Benedetti MM
Thromb Haemost; 2007 Sep; 98(3):635-41. PubMed ID: 17849053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
